Directed evolution of a protein: selection of potent neutrophil elastase inhibitors displayed on M13 fusion phage.
- 15 March 1992
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 89 (6) , 2429-2433
- https://doi.org/10.1073/pnas.89.6.2429
Abstract
Inhibitors of human neutrophil elastase were engineered by designing and producing a library of phage-displayed protease inhibitory domains derived from wild-type bovine pancreatic trypsin inhibitor and fractionating the library for binding to the target protease. The affinity of one of the engineered variants for human neutrophil elastase (Kd = 1.0 pM) is 3.6 x 10(6)-fold higher than that of the parental protein and exceeds the highest affinity reported for any reversible human neutrophil elastase inhibitor by 50-fold. Thus the display phage method has allowed us to obtain protein derivatives that exhibit greatly increased affinity for a predetermined target. The technology can be applied to design high-affinity proteins for a wide variety of target molecules.Keywords
This publication has 23 references indexed in Scilit:
- Multiple display of foreign peptides on a filamentous bacteriophageJournal of Molecular Biology, 1991
- Peptides on phage: a vast library of peptides for identifying ligands.Proceedings of the National Academy of Sciences, 1990
- Random Peptide Libraries: a Source of Specific Protein Binding MoleculesScience, 1990
- Hormone phage: An enrichment method for variant proteins with altered binding propertiesProteins-Structure Function and Bioinformatics, 1990
- Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol)The Journal of Thoracic and Cardiovascular Surgery, 1989
- Structure, function, and control of neutrophil proteinasesThe American Journal of Medicine, 1988
- Biosynthesis, Processing, and Evolution of Bovine Pancreatic Trypsin InhibitorCold Spring Harbor Symposia on Quantitative Biology, 1987
- Production of native, correctly folded bovine pancreatic trypsin inhibitor by Escherichia coli.Journal of Biological Chemistry, 1986
- Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site.Journal of Biological Chemistry, 1979
- Pancreatic trypsin inhibitor. 2. Reaction with trypsinBiochemical Journal, 1953